AstraZeneca may launch cash bid for Amarin, Daily Mail reports

According to the Daily Mail, AstraZeneca (AZN) may be planning to launch a cash bid for Amarin (AMRN). The Mail says other larger pharmaceutical companies, like Merck (MRK), Eli Lilly (LLY), Abbott (ABT) and Pfizer (PFE), "would love to get their hands" on Amarin for Vascepa.

View Comments (-5)